Product Liability MVP: O'Melveny's Charles Lifland

Law360, New York (December 12, 2012, 7:09 PM EST) -- O'Melveny & Myers LLP partner Charles Lifland scored recent appellate victories for Johnson & Johnson and Merck & Co. Inc. allowing the drug companies to avoid paying millions in punitive damages and dodge costly failure-to-warn claims, securing himself a spot among Law360's Product Liability MVPs.

An experienced litigator who is used to high-stakes cases, Lifland came through in big spots for his clients in both state and federal appeals courts. He persuaded a New York appeals court that a plaintiff blaming Tylenol for liver failure lacked...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.